Company news

Ludwig Enterprises, Inc. news in 2024

Ludwig Enterprises, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Ludwig Enterprises Begins PCR Validation Test Process

November 6, 2024

Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

October 23, 2024

CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

September 23, 2024

Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

September 23, 2024

Ludwig Announces Acquisition of Intellectual Property and Patent

September 16, 2024

Ludwig Announces Substantial Corporate Initiatives

August 13, 2024

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

July 8, 2024

Ludwig Enterprises Inc (OTC: LUDG) Funds Incurable Brain Cancer Study

March 26, 2024

Ludwig Enterprises Inc (OTC: LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024

March 18, 2024

Ludwig Enterprises Inc. (OTC: LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers

March 5, 2024

Ludwig Enterprises mRNA Bladder Cancer Study to be Launched

January 30, 2024

Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program

January 8, 2024

Decks in 2024